Tuesday, August 05, 2014 4:34:01 PM
“HeartWare Presentation At The Canaccord Genuity 34th Annual Growth Conference To Be Webcast” (8-14-14 9amET)
http://ir.heartware.com/phoenix.zhtml?c=187755&p=irol-newsArticle&ID=1955364
FRAMINGHAM, Aug. 5, 2014: HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 34th Annual Growth Conference at 9:00amET on Thursday, August 14, 2014. The conference is being held August 13-14 at the InterContinental Boston.
A live webcast of the Company's presentation at the conference will be available via a link provided at http://www.heartware.com . . .
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM